TRLV · Annual Report (Form 10-K) · Filed February 26, 2026

Trulieve Cannabis Corp — 10-K exhibit

exhibit232marcumconsent2025.htm

Trulieve Cannabis Corp on Boardroom Alpha

Document

Exhibit 23.2

Independent Registered Public Accounting Firm’s Consent

We consent to the incorporation by reference in this Registration Statement on Form S-3 (File No. 333-288432) and Form S-8 (File Nos. 333-289299, 333-272967, 333-260098, 333-259175, and 333-280401) of our report dated February 29, 2024, except for the Segment Reporting & Reporting Units in Note 3, as to which date is February 27, 2025 relating to the financial statements of Trulieve Cannabis Corp. (the “Company”) appearing in the Annual Report on Form 10-K of the Company for the year ended December 31, 2025. We were dismissed as auditors on March 25, 2024 and, accordingly, we have not performed any audit or review procedures with respect to any financial statements appearing in such Registration Statement for the periods after the date of our dismissal.

/s/ Marcum LLP

Tampa, FL

February 26, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer